Skip to content
Past Exams

2019 NURS6630 Pharmacology Week 11 Final Exam With Answers (76 Solved Questions)

Study smarter with 2019 NURS6630 Pharmacology Week 11 Final Exam With Answers, a collection of past exams that highlight important concepts and question types.

Preview 6 of 19 pages

See the first 6 pages exactly as they appear in the document.

  1. Page 1
    Read page 1 as text

    User Cynthia Rochelle Archie Course NURS-6630N Test Week 11 Final Exam Started 2/6/19 9:14 AM Submitted 2/6/19 11:08 AM Due Date 2/11/19 1:59 AM Status Completed Attempt Score 73 out of 75 points Time Elapsed 1 hour, 54 minutes out of 2 hours Results Displayed Submitted Answers  Question 1 1 out of 1 points Mrs. Rosen is a 49-year-old patient who is experiencing fibro-fog. What does the PMHNP prescribe for Mrs. Rosen to improve this condition? Selected Answer: D. All of the above  Question 2 0 out of 1 points An elderly woman with a history of Alzheimer’s disease, coronary artery disease, and myocardial infarction had a fall at home 3 months ago that resulted in her receiving an open reduction internal fixation. While assessing this patient, the PMHNP is made aware that the patient continues to experience mild to moderate pain. What is the PMHNP most likely to do? Selected Answer: A. Order an X-ray because it is possible that she dislocated her hip.  Question 3 1 out of 1 points The PMHNP is caring for a patient who reports excessive arousal at nighttime. What could the PMHNP use for a time-limited duration to shift the patient’s brain from a hyperactive state to a sleep state? Selected Answer: B. Benzodiazepi

  2. Page 2
  3. Page 3
    Read page 3 as text

    nes  Question 4 1 out of 1 points A patient addicted to heroin is receiving treatment for detoxification. He begins to experience tachycardia, tremors, and diaphoresis. What medication will the PMHNP prescribe for this patient? Selected Answer: D. Clonidine (Catapres)  Question 5 1 out of 1 points The PMHNP prescribes gabapentin (Neurontin) for a patient’s chronic pain. How does the PMHNP anticipate the drug to work? Selected Answer: A. It will bind to the alpha-2-delta ligand subunit of voltage-sensitive calcium channels.  Question 6 1 out of 1 points A patient with hypersexual disorder is being assessed for possible pharmacologic treatment. Why does the PMHNP prescribe an antiandrogen for this patient? Selected Answer: C. It will block testosterone.  Question 7 1 out of 1 points Which statement best describes a pharmacological approach to treating patients for impulsive aggression? Selected Answer: D. Opioid antagonists can be used to reduce drive.

  4. Page 4
    Read page 4 as text

     Question 8 1 out of 1 points A 26-year-old female patient with nicotine dependence and a history of anxiety presents with symptoms of attention deficit hyperactivity disorder (ADHD). Based on the assessment, what does the PMHNP consider? Selected Answer: A. ADHD is often not the focus of treatment in adults with comorbid conditions.  Question 9 1 out of 1 points A patient with irritable bowel syndrome reports chronic stomach pain. The PMHNP wants to prescribe the patient an agent that will cause irrelevant nociceptive inputs from the pain to be ignored and no longer perceived as painful. Which drug will the PMHNP prescribe? Selected Answer: C. Duloxetine (Cymbalta)  Question 10 1 out of 1 points Parents of a 12-year-old boy want to consider attention deficit hyperactivity disorder (ADHD) medication for their son. Which medication would the PMHNP start? Selected Answer: All of the above could potentially treat their son’s symptoms.  Question 11 1 out of 1 points Which of the following is a true statement regarding the use of stimulants to treat attention deficit hyperactivity disorder (ADHD)? Selected Answer: B. Signal strength output is increased by dialing up the release of dopamine (DA) and norepinephrine (NE).  Question 12 1 out of 1 points Mr. Peterson is meeting with the PMHNP to discuss healthier dietary habits. With a BMI of

  5. Page 5
    Read page 5 as text

    33, Mr. Peterson is obese and needs to modify his food intake. “Sometimes I think I’m addicted to food the way some people are addicted to drugs,” he says. Which statement best describes the neurobiological parallels between food and drug addiction? Selected Answer: A. There is decreased activation of the prefrontal cortex.  Question 13 1 out of 1 points A 72-year-old male patient is in the early stages of Alzheimer’s disease. The PMHNP determines that improving memory is a key consideration in selecting a medication. Which of the following would be an appropriate choice? Selected Answer: D. All of the above  Question 14 1 out of 1 points A patient is prescribed D-methylphenidate, 10-mg extended-release capsules. What should the PMHNP include when discussing the side effects with the patient? Selected Answer: C. The medication can affect your blood pressure.  Question 15 1 out of 1 points The parents of a 7-year-old patient with ADHD are concerned about the effects of stimulants on their child. The parents prefer to start pharmacological treatment with a non-stimulant. Which medication will the PMHNP will most likely prescribe? Selected Answer: A. Stratt era  Question 16 1 out of 1 points The PMHNP is assessing a patient who has expressed suicidal intent and is now stating that he is hearing voices and sees people chasing him. The PMHNP identifies these symptoms to be associated with which of the following?

  6. Page 6
    Read page 6 as text

    Selected Answer: C. “Bath salt” intoxication  Question 17 1 out of 1 points An 80-year-old female patient diagnosed with Stage II Alzheimer’s has a history of irritable bowel syndrome. Which cholinergic drug may be the best choice for treatment given the patient’s gastrointestinal problems? Selected Answer: A. Donepezil (Aricept)  Question 18 1 out of 1 points A 63-year-old patient presents with the following symptoms. The PMHNP determines which set of symptoms warrant prescribing a medication? Select the answer that is matched with an appropriate treatment. Selected Answer: B. Impairment in the ability to learn and retain new information is most problematic, and an appropriate treatment option would be donepezil.  Question 19 1 out of 1 points The PMHNP is caring for a patient with chronic insomnia who is worried about pharmacological treatment because the patient does not want to experience dependence. Which pharmacological treatment approach will the PMHNP likely select for this patient for a limited duration, while searching and correcting the underlying pathology associated with the insomnia? Selected Answer: D. Non-benzodiazepine hypnotics  Question 20 1 out of 1 points The PMHNP is performing a quality assurance peer review of the chart of another PMHNP. Upon review, the PMHNP reviews the chart of an older adult patient in long-term care facility who has chronic insomnia. The chart indicates that the patient has been receiving hypnotics on a nightly basis. What does the PMHNP find problematic about this documentation?

13 more pages in the full document

Unlock it once and it stays in your library, ready to chat with or turn into flashcards.

Unlock the full document

More Nursing study materials

See all

Study this document with CramX

Once it is in your library, every tool can work from it.